Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    LAROPIPRANT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 571170-77-9, Mk 0524, Mk-0524, Cardaptive, Cordaptive, Chembl426559
    Molecular Formula
    C21H19ClFNO4S
    Molecular Weight
    435.9  g/mol
    InChI Key
    NXFFJDQHYLNEJK-CYBMUJFWSA-N
    FDA UNII
    G7N11T8O78
    Laropiprant is a prostaglandin D2 receptor (DP1) antagonist with niacin-induced vasodilation inhibiting activity. Laropiprant binds to and inhibits the activity of DP1, a G-protein coupled receptor. Via competing with prostaglandin D2 (PG D2) for binding to DP1, this agent prevents PG D2-induced vasodilation and increased blood flow. As niacin induces the synthesis of PG D2, predominantly in the skin, administration of laropiprant may prevent niacin-induced vasodilation in the skin and facial flushing.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid
    2.1.2 InChI
    InChI=1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1
    2.1.3 InChI Key
    NXFFJDQHYLNEJK-CYBMUJFWSA-N
    2.1.4 Canonical SMILES
    CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CCC3CC(=O)O)CC4=CC=C(C=C4)Cl)F
    2.1.5 Isomeric SMILES
    CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CC[C@@H]3CC(=O)O)CC4=CC=C(C=C4)Cl)F
    2.2 Other Identifiers
    2.2.1 UNII
    G7N11T8O78
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (3r)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl Acetic Acid

    2. Mk-0524

    2.3.2 Depositor-Supplied Synonyms

    1. 571170-77-9

    2. Mk 0524

    3. Mk-0524

    4. Cardaptive

    5. Cordaptive

    6. Chembl426559

    7. G7n11t8o78

    8. 2-[(3r)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1h-cyclopenta[b]indol-3-yl]acetic Acid

    9. ((3r)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetic Acid

    10. (-)-((3r)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetic Acid

    11. 2-[(3r)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methanesulfonyl-1h,2h,3h,4h-cyclopenta[b]indol-3-yl]acetic Acid

    12. Cyclopent(b)indole-3-acetic Acid, 4-((4-chlorophenyl)methyl)-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-, (3r)-

    13. Laropiprant [usan]

    14. Tedaptive

    15. Unii-g7n11t8o78

    16. Laropiprant [usan:inn:ban]

    17. Cyclopent[b]indole-3-acetic Acid, 4-[(4-chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-, (3r)-

    18. [14c]-laropiprant

    19. Laropiprant [mi]

    20. Laropiprant [inn]

    21. Laropiprant (inn/usan)

    22. Laropiprant; Mk-0524

    23. Laropiprant (mk-0524)

    24. Laropiprant [mart.]

    25. Laropiprant [who-dd]

    26. Schembl991107

    27. Laropiprant [ema Epar]

    28. Amot0189

    29. Gtpl3356

    30. Dtxsid60205756

    31. Chebi:135942

    32. Bcpp000161

    33. Bcp02136

    34. Ex-a2099

    35. Zinc3961849

    36. Bdbm50205275

    37. Laropiprant,cas:571170-77-9

    38. Mk0524

    39. Akos030526850

    40. Am81247

    41. At34794

    42. Bcp9000944

    43. Cardaptive; Mk 0524; Mk-0524

    44. Cs-0539

    45. Db11629

    46. Ncgc00345790-10

    47. Ac-35835

    48. As-17012

    49. Hy-50175

    50. A25234

    51. D08940

    52. Q412291

    53. [(3r)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic Acid

    54. Laropiprant;(r)-2-(4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic Acid

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 435.9 g/mol
    Molecular Formula C21H19ClFNO4S
    XLogP33.5
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count5
    Exact Mass435.0707351 g/mol
    Monoisotopic Mass435.0707351 g/mol
    Topological Polar Surface Area84.8 Ų
    Heavy Atom Count29
    Formal Charge0
    Complexity721
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1